William John Sibold insider trades

Open-market stock purchases and sales by William John Sibold, President and CEO at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since May 3, 2011.

Recent trades

DateStockTradeValue
Mar 6, 2026MDGL Madrigal Pharmaceuticals, IncSold$718K
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jan 26, 2026MDGL Madrigal Pharmaceuticals, IncSold$777K
Dec 4, 2025MDGL Madrigal Pharmaceuticals, IncSold$1.4M
Dec 3, 2025MDGL Madrigal Pharmaceuticals, IncBought (not open market)—

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: 8 sales, last Mar 6, 2026
  • AVNR Avanir Pharmaceuticals, Inc: other filings, last May 3, 2011

Get free alerts when William John Sibold files a new trade →